Short description
Kinea Bio is a patient-focused biotechnology startup that aims to speed the development of next-generation AAV-based gene treatments.
Description
Kinea Bio is a patient-focused biotechnology startup that aims to speed the development of next-generation AAV-based gene treatments for neuromuscular illnesses.
Total funding
$$2020202
Sign in for full access
Location
Seattle, Washington, United States, North America
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
No Way
Sign in for full access